Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin sodium-clavulanate 10:1 vs 5:1 injection in acute infections
CTR20130090Phase 2Active
- Sponsor
- Suzhou Erye Pharmaceutical Co., Ltd.
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin + clavulanate in purulent tonsillitis, pulmonary infection, urinary tract infection (UTI), There is no single canonical disease name for "acute bacterial infection" as it refers to a broad category of diseases rather than a specific condition., sponsored by Suzhou Erye Pharmaceutical Co., Ltd.. Started May 2013; status: active.
02
Drugs
amoxicillin + clavulanate
03
Conditions
purulent tonsillitispulmonary infectionurinary tract infection (UTI)There is no single canonical disease name for "acute bacterial infection" as it refers to a broad category of diseases rather than a specific condition.
Beyond the preview
Go deeper on CTR20130090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130090.